NOTCH1 and cervical squamous intraepithelial neoplasia: To summarize the findings at baseline analysis, patients with poorer response to trastuzumab treatment were found to share common features such as having a diffuse Lauren classification, low CIN, and baseline NOTCH1 deletion, which suggests that these factors may be indicative of primary trastuzumab resistance in patients.